Horizon Pharma Ord (HZNP) 19.00 $HZNP Horizon (HZNP)

New Post Public Reply Private Reply Replies (0) Message Board

Jul 11, 2016 at 11:06 AM

Horizon Pharma Ord (HZNP) 19.00 $HZNP

Horizon (HZNP) Stock Up on Ravicti Label Expansion Filing
Zacks Equity Research - Zacks Investment Research - Thu Jun 30, 9:11AM CDT
Horizon Pharma (HZNP) announced that it is looking to expand the approved age range for Ravicti for chronic management of urea cycle disorders in the U.S.
ANIP: 56.37 (-0.14), HZNP: 19.00 (+0.29), RTRX: 18.53 (-0.12), BMY: 75.22 (-0.06)

Horizon Pharma plc Submits Supplemental New Drug Application for RAVICTI(R) (glycerol phenylbutyrate) Oral Liquid to Expand Age Range for Management of Urea Cycle Disorders
Marketwired - Wed Jun 29, 6:00AM CDT
The Company Has Also Initiated a European Managed Access Program for RAVICTI
HZNP: 19.00 (+0.29)

Horizon Pharma plc Added to Russell 2000(R) and 3000(R) Indexes
Marketwired - Mon Jun 27, 3:15PM CDT
DUBLIN, IRELAND--(Marketwired - Jun 27, 2016) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced it has been added to the U.S. Russell 2000® and 3000® Indexes, effective today, as part of the 2016 Russell indexes reconstitution.
HZNP: 19.00 (+0.29)

Drugs - Generic Stocks Technical Data - Allergan, Mylan, Horizon Pharma, and Celator Pharma
PR Newswire - Fri Jun 17, 7:00AM CDT
On Thursday, June 16, 2016, the NASDAQ Composite ended the trading session at 4,844.92, up 0.21%; the Dow Jones Industrial Average advanced 0.53% to finish at 17,733.10; and the S&P 500 closed at 2,077.99, up 0.31%. The gains were broad based as seven out of nine sectors ended the session in positive. Stock-Callers.com has initiated coverage on the following equities: Allergan PLC (NYSE: AGN), Mylan N.V. (NASDAQ: MYL), Horizon Pharma PLC (NASDAQ: HZNP), and Celator Pharmaceuticals Inc. (NASDAQ: CPXX). Learn more about these stocks by accessing their free trade alerts at:
CPXX: 30.25 (+0.01), AGN: 240.45 (-0.14), HZNP: 19.00 (+0.29), MYL: 44.81 (+0.27)

Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting
PR Newswire - Tue Jun 07, 2:42PM CDT
Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI) a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced that at its 2016 Annual Meeting of Shareholders held in Toronto, all nominees listed in the management proxy circular dated May 4, 2016 were elected as directors of the Company.
NRI.TO: 7.10 (-0.20), HZNP: 19.00 (+0.29)

Nuvo Pharmaceuticals(TM) Announces Director Election Results of its Annual General Meeting
CNW Group - Tue Jun 07, 2:42PM CDT
Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI) a commercial healthcare company with a portfolio of commercial products and pharmaceutical manufacturing capabilities, today announced that at its 2016 Annual Meeting of Shareholders held in Toronto, all nominees listed in the management proxy circular dated May 4, 2016 were elected as directors of the Company.
NRI.TO: 7.10 (-0.20), HZNP: 19.00 (+0.29)

Horizon Pharma plc to Participate in Jefferies 2016 Healthcare Conference
Marketwired - Thu Jun 02, 6:00AM CDT
DUBLIN, IRELAND--(Marketwired - Jun 2, 2016) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will present at the Jefferies 2016 Healthcare Conference at 2 p.m. EDT on June 9, 2016 in New York City, NY.
HZNP: 19.00 (+0.29)

Horizon Pharma plc Announces the U.S. Patent and Trademark Office Issuance of an Additional Notice of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets
Marketwire Canada - Wed Jun 01, 6:00AM CDT
Will Represent the Fifteenth U.S. Patent Listed in the Orange Book for VIMOVO
HZNP: 19.00 (+0.29), ARZ.TO: 4.85 (+0.15), ARLZ: 3.71 (+0.10)

Biotech Stock Roundup: XenoPort Soars on Acquisition Deal, AbbVie Crohn's Disease Drug Fares Well
Arpita Dutt - Zacks Investment Research - Wed May 25, 2:02PM CDT
Deals and acquisitions were in focus this week in the biotech sector while AbbVie's (ABBV) recently in-licensed candidate fared well in a mid-stage study.
VRTX: 89.77 (+0.81), HZNP: 19.00 (+0.29), ICPT: 153.44 (+1.71), ABBV: 64.55 (+0.39), ACOR: 25.59 (-0.62), BIOD: 0.30 (-0.01), XNPT: 7.07 (+0.05)

Horizon (HZNP) to Buy Global Rights to Actimmune, Stock Down
Zacks Equity Research - Zacks Investment Research - Fri May 20, 8:10AM CDT
Horizon Pharma (HZNP) will acquire global rights to Actimmune from Boehringer Ingelheim. The deal is expected to close by year end.
ANIP: 56.37 (-0.14), HZNP: 19.00 (+0.29), RTRX: 18.53 (-0.12), BMY: 75.22 (-0.06)

Horizon Pharma plc to Acquire Worldwide Rights to Interferon Gamma-1b From Boehringer Ingelheim International GmbH
Marketwire Canada - Thu May 19, 6:00AM CDT
Also Licenses Rights to Patents and Pending Applications Covering Methods for Treating Friedreich's Ataxia With Interferon Gamma-1b; Company Currently Owns the Rights to Interferon Gamma-1b Under the Trade Name ACTIMMUNE(R) in the United States, Canada and Japan
HZNP: 19.00 (+0.29)

Horizon Pharma plc to Participate in UBS Global Healthcare Conference
Marketwire Canada - Wed May 18, 4:45PM CDT
DUBLIN, IRELAND--(Marketwired - May 18, 2016) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that Timothy P. Walbert, chairman, president and chief executive officer, will present at the UBS Global Healthcare Conference at 11 a.m. EDT on May 25, 2016 in New York City, NY.
HZNP: 19.00 (+0.29)

Horizon Pharma plc Announces That Marilyn Vetter Honored as a 2016 Healthcare Businesswomen's Association Luminary
Marketwired - Thu May 12, 7:00AM CDT
DUBLIN, IRELAND--(Marketwired - May 12, 2016) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that Marilyn Vetter, vice president, government and public affairs, has been named a 2016 Healthcare Businesswomen's Association (HBA) Luminary. Marilyn will be honored today at the 27th annual Woman of the Year event in New York.
HZNP: 19.00 (+0.29)

Horizon Pharma plc Announces Settlement of PENNSAID(R) (diclofenac sodium topical solution) 2% w/w Patent Litigation With Teligent, Inc.
Marketwire Canada - Thu May 12, 6:00AM CDT
DUBLIN, IRELAND--(Marketwired - May 12, 2016) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, today announced that its affiliates have entered into a settlement and license agreement with Teligent, Inc. to resolve pending patent litigation involving PENNSAID® (diclofenac sodium topical solution) 2% w/w (PENNSAID® 2%).
HZNP: 19.00 (+0.29), TLGT: 8.13 (+0.06)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Blokees Unveils 90+ New Wonders at Shanghai Fest

A Grand Stage for New Arrivals Picture this: In the bustling and glittering chaos that was the Wonder Festival Shanghai 2026, held from October 3 to 4, Blokees laid down a major marker. More than 500 products, an artillery of imagination and craftsmanship, were on deck across their key lines—Blokees Model Kits and BLOKEES WHEELS. With 90 brand-new creations making their...

Lawsuit Highlights Inaction in School Bus Tragedy

Seeking Justice Amid Heartbreak Tragedy rarely arrives whispered on the wind—more often, it's the train wreck some saw coming long before it hits. The tragic death of Jenna Menias, a 6-year-old from Frankfort, Illinois, falls squarely in this camp. The family's legal lions, Corboy & Demetrio, have slapped two school districts—District 210 and 157-C—with a wrongful...

SiBionics and PharmaSens Unveil Diabetes Tech at EASD

Shaking Up Diabetes Care: New Tech Unveiled Imagine a world where managing diabetes isn't a juggling act with multiple devices. That's precisely the future SiBionics and PharmaSens are pitching at the European Association for the Study of Diabetes (EASD) 2026 in Milan. Now, let me tell you, these guys aren't just playing around with ideas; they're aiming to radically...

Power Knot MEA Wins THE BIZZ 2026 for Excellence

Setting the Pace in Waste Management If there's one thing that sticks in my craw, it's how businesses handle food waste. Power Knot Middle East (PKME) seems to have cracked the code by not just leading the charge in organic waste management but also bagging THE BIZZ 2026 award. They’re not just playing industry games; PKME's pulling the strings with real leadership and...

Black Culture Icon: Plastic-Covered Couch Takes Stage

A Plastic-Laden Piece of History Makes Art Who'd have thought a plastic-covered couch would turn into a cultural artifact? This iconic staple in Black households has done just that, debuting at Brooklyn's CultureCon in a fresh guise. It's more than just an upcycled furniture piece; it's a living archive that encapsulates Black culture, joy, and resilience. The Heart...

Unpacking Monteverde's M&A Investigations Hold your horses, folks! The M&A Class Action Firm is stirring the pot with its latest inquiries into some high-profile mergers. We're looking at Lisata Therapeutics, Flag Ship Acquisition Corporation, Baldwin Insurance Group, and ACV Auctions. So what's got Juan Monteverde's legal eagles swooping in on these deals? Well, are we...

Monster Energy Dominates Skateboard Podium at SLS Paris

Monster Energy's Skateboard Triumph Hold the front page, because Monster Energy just pulled off a clean sweep in Paris. The company's team riders dominated the Men's Skateboard Street competition at the SLS Paris 2026, with the iconic Nyjah Huston snagging the top spot. It's a story filled with triumph, grit, and a dash of raw talent in a vibrant field of international...

ARTBOX Brings Korean Lifestyle Magic to LA Pop-Up

ARTBOX: From Seoul to La-La Land Here's what caught my eye. It's 2026, and Korean lifestyle retailer ARTBOX is making a splash in the U.S.—kicking things off with a pop-up in LA. Now, usually, I'd be skeptical about pop-ups, but you've got to admire the audacity and timing here. They've picked Melrose Avenue, a hotspot for all things trendy, to introduce their mix of...

Monteverde's Equity Alert: Scrutinizing Recent M&A Deals

Diving Into M&A Deals Under Monteverde's Lens Wall Street’s not just about suits and skyscrapers; it’s about the nitty-gritty of deals and whether those numbers add up in the investor's favor. So, when Monteverde & Associates PC throws its weight into scrutinizing mergers and acquisitions, you better believe it's worth a second look. See, they’re digging into four...

Monteverde Probes Four Key M&A Deals for Fairness

Examining the Intricacies of Pending M&A The merger and acquisition landscape can be vicious, especially when the sharks—those pesky class action lawyers—start circling. And let me tell you, Monteverde & Associates PC is diving headfirst into the fray, launching inquiries into a handful of these deals. This isn't your first stroll down Wall Street if you’ve seen one...